[BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY

2020 ◽  
Vol 59 (10) ◽  
pp. S264-S265
Author(s):  
Helen Heussler ◽  
Michael Duhig ◽  
Terry Hurst ◽  
Carol O'Neill ◽  
Donna Gutterman ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Children And Adolescents ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Phase 2 ◽  
Open Label ◽  
Phase 2 Study ◽  
Adolescents With Autism ◽  
Open Label Phase

scholarly journals Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

2016 ◽  
Vol 42 (7) ◽  
pp. 1390-1398 ◽  
Author(s):  
Jeremy Veenstra-VanderWeele ◽  
Edwin H Cook ◽  
Bryan H King ◽  
Peter Zarevics ◽  
Maryann Cherubini ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Children And Adolescents ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Phase 2 ◽  
Randomized Controlled ◽  
Phase 2 Trial ◽  
Adolescents With Autism

Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder

2021 ◽  
Vol 385 (16) ◽  
pp. 1462-1473
Author(s):  
Linmarie Sikich ◽  
Alexander Kolevzon ◽  
Bryan H. King ◽  
Christopher J. McDougle ◽  
Kevin B. Sanders ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Children And Adolescents ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Adolescents With Autism
Sign in / Sign up

Export Citation Format

Share Document